Title:
抗ＣＤ３９抗体と養子細胞療法とを含む併用療法
Document Type and Number:
Japanese Patent JP2023521041
Kind Code:
A
Abstract:
抗ＣＤ３９抗体及び養子細胞療法との抗体併用療法が提供される。【選択図】なし
Inventors:
Beards, Courtney
Moesta, Akim
malandro, nicole
Moesta, Akim
malandro, nicole
Application Number:
JP2022560271A
Publication Date:
May 23, 2023
Filing Date:
April 02, 2021
Export Citation:
Assignee:
TRISHULA THERAPEUTICS,INC.
International Classes:
A61K39/395; A61K35/17; A61P35/00; A61P43/00; C07K16/28; C12N5/0783; C12N5/10; C12N15/12; C12N15/13; C12N15/62
Attorney, Agent or Firm:
Mitsuhiro Imamura
Previous Patent: Portable cooler with active temperature control
Next Patent: Targeted inhibition using engineered oligonucleotides
Next Patent: Targeted inhibition using engineered oligonucleotides